Patent ID: 8129337

Claim:
A composition comprising a blood glucose level maintaining amount of a combination of: 5 to 500 mg EGCG and a protein hydrolysate, wherein the protein hydrolysate is selected from the group consisting of: a) a whey hydrolysate which comprises peptides wherein the molar fraction of peptides carrying a carboxy terminal proline is at least 8%; b) a casein hydrolysate which comprises peptides wherein the molar fraction of peptide carrying a carboxy terminal proline is at least 25%; c) a soy hydrolysate which comprises peptides wherein the molar fraction of peptide carrying a carboxy terminal proline is at least 20%; d) a gluten hydrolysate which comprises peptides wherein the molar fraction of peptide carrying a carboxy terminal proline is at least 20%; and e) a barley hydrolysate which comprises peptides wherein the molar fraction of peptide carrying a carboxy terminal proline is at least 20%, and at least one of: ligustilide or other phthalides or herbal extracts containing ligustilide or other phthalides, coenzyme Q-q0, resveratrol, panthethine or a metabolite thereof, phytanic acid, lipoic acid, and policosanol.